相关实验视频
Updated: Jan 18, 2026

12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
19.3K
药剂师在虚拟糖尿病诊所的干预:成本效益可行性研究
Sinaa Al-Aqeel1, Alaa Mutlaq2, Njood Alkhalifa1
1Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.
Healthcare (Basel, Switzerland)
|September 13, 2025
概括
药剂师通过虚拟诊所有效管理糖尿病患者,提供教育和咨询. 为未来的成本效益研究收集数据显示了可行性,但强调了患者结果数据的挑战.
科学领域:
- 药理学 药理学是指药理学的学科.
- 数字健康数字健康
- 医疗保健管理的管理
背景情况:
- 远程医疗改善了糖尿病护理和医疗保健的准入.
- 虚拟药剂师主导的糖尿病诊所 (PLDC) 提供远程患者管理.
- 本研究侧重于在虚拟环境中的干预措施和可行性.
研究的目的:
- 在虚拟的PLDC中描述药剂师干预.
- 评估未来PLDC的成本效益研究的可行性.
- 评估远程药房在糖尿病管理中的作用.
主要方法:
- 预期的观察性可行性研究.
- 塞哈虚拟医院实习药剂师收集的数据.
- 通过电话咨询收集的患者数据.
主要成果:
- 75名患者 (58.7%为女性,86.6%为2型糖尿病) 参与了这项研究.
- 进行了179次干预,主要是患者教育和咨询.
- 对干预措施进行可行的数据捕获,但患者结局数据不完整.
结论:
- 药剂师在虚拟PLDC中有效地识别和管理糖尿病问题.
- 证实了成本效益研究的可行性,并确定了挑战.
- 虚拟PLDC展示了糖尿病护理的潜力.
相关概念视频
Diabetes: Management and Pharmacotherapy
870
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
870
Therapeutic Drug Monitoring: Affecting Factors
202
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
202
Bioavailability Study Design: Healthy Subjects Versus Patients
144
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
144
Dosage Regimens: Partial Pharmacokinetic Parameters
155
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
155
Dosage Regimen: Individualization
167
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
167
Therapeutic Drug Monitoring: Overview and Classification
315
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
315

